Results
|
|
1001.
|
|
|
|
1002.
|
|
|
|
1003.
|
|
|
|
1004.
|
|
|
|
1005.
|
|
|
|
1006.
|
|
|
|
1007.
|
|
|
|
1008.
|
|
|
|
1009.
|
|
|
|
1010.
|
|
|
|
1011.
|
|
|
|
1012.
|
|
|
|
1013.
|
|
|
|
1014.
|
|
|
|
1015.
|
|
|
|
1016.
|
|
|
|
1017.
|
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol. [electronic resource] by
- Rabe, Klaus F
- Martinez, Fernando J
- Ferguson, Gary T
- Wang, Chen
- Singh, Dave
- Wedzicha, Jadwiga A
- Trivedi, Roopa
- St Rose, Earl
- Ballal, Shaila
- McLaren, Julie
- Darken, Patrick
- Reisner, Colin
- Dorinsky, Paul
Producer: 20200803
In:
Respiratory medicine vol. 158
Availability: No items available.
|
|
|
1018.
|
|
|
|
1019.
|
|
|
|
1020.
|
|